Skip to main content

Hereditary Tyrosinemia

Pathogenesis, Screening and Management

  • Book
  • © 2017

Access provided by CONRICYT-eBooks

Overview

  • A comprehensive account of Tyrosinemia
  • Written by some of the world’s leading experts in this field
  • Latest in-depth reviews on this important metabolic disease

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 959)

Buy print copy

Softcover Book USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

About this book

Hereditary tyrosinemia type 1 (HT1), the most severe inborn error of the tyrosine degradation pathway, is due to a deficiency in fumarylacetoacetate hydrolase (FAH). The worldwide frequency of HT1 is one per 100,000 births, but some regions have a significantly higher incidence (1:1,800). The FAH defect results in the accumulation of toxic metabolites, mainly in the liver. If left untreated, HT1 is usually fatal before the age of two. HT1 patients develop several chronic complications including cirrhosis with a high risk of hepatocellular carcinoma (HCC) and neuropsychological impairment. Treatment comprises an inhibitor of the pathway, Nitisinone, a strict dietary treatment or liver transplantation. Early treatment is important to avoid HCC. The book includes the latest developments on the molecular basis of HT1, its pathology, screening and diagnosis and management of the disease written by leading scientists, geneticists, hepatologists and clinicians in the field.

Similar content being viewed by others

Keywords

Table of contents (21 chapters)

  1. Hereditary Tyrosinemia Type I

  2. Molecular Basis of HT1

  3. Pathology

  4. Screening

Editors and Affiliations

  • Department of Molecular Biology, Medical Biochemistry and Pathology, Medical School, Université Laval, Québec, Canada

    Robert M. Tanguay

Bibliographic Information

  • Book Title: Hereditary Tyrosinemia

  • Book Subtitle: Pathogenesis, Screening and Management

  • Editors: Robert M. Tanguay

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-3-319-55780-9

  • Publisher: Springer Cham

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2017

  • Hardcover ISBN: 978-3-319-55779-3Published: 10 August 2017

  • Softcover ISBN: 978-3-319-85745-9Published: 12 August 2018

  • eBook ISBN: 978-3-319-55780-9Published: 27 July 2017

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: XV, 247

  • Number of Illustrations: 17 b/w illustrations, 36 illustrations in colour

  • Topics: Protein Science

Publish with us